Related Experiment Videos
NKT cells in cardiovascular diseases.
Gijs H M van Puijvelde1, Johan Kuiper1
1Division of Biopharmaceutics, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333CC Leiden, The Netherlands.
European Journal of Pharmacology
|April 2, 2017
Summary
Natural killer T (NKT) cells contribute to atherosclerosis development by releasing harmful substances. Targeting these pro-atherogenic NKT cells offers a promising new strategy for cardiovascular disease prevention and treatment.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Atherosclerosis Research
Background:
- Cardiovascular diseases remain a leading global cause of death despite current treatments.
- Atherosclerosis, characterized by arterial inflammation and lipid accumulation, underlies most cardiovascular diseases.
- Natural killer T (NKT) cells and antigen-presenting cells are present in atherosclerotic lesions.
Purpose of the Study:
- To review the critical role of NKT cells in cardiovascular disease pathogenesis.
- To discuss NKT cells as potential therapeutic targets for atherosclerosis.
- To explore lipid transfer proteins and NKT cell activation mechanisms in atherosclerosis.
Main Methods:
- Literature review of studies on NKT cells in atherosclerosis.
- Analysis of NKT cell cytokine and cytotoxin secretion.
- Discussion of lipid metabolism and CD1d antigen presentation.
Main Results:
- NKT cells secrete pro-atherogenic cytokines and cytotoxins, contributing to disease progression.
- NKT cells play a significant role in the pathogenesis of atherosclerosis.
- Lipid transfer proteins are involved in CD1d loading and NKT cell activation.
Conclusions:
- Pro-atherogenic NKT cells are key players in cardiovascular disease development.
- Targeting NKT cells presents a novel therapeutic avenue for atherosclerosis.
- Understanding lipid-protein interactions is crucial for NKT cell-mediated atherosclerosis therapies.